Caution when lean body weight is used as a size descriptor for obese subjects

被引:39
作者
Green, B [1 ]
Duffull, S [1 ]
机构
[1] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia
关键词
D O I
10.1067/mcp.2002.129306
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:743 / 744
页数:2
相关论文
共 8 条
[1]  
[Anonymous], 1976, RES OBESITY
[2]   RELATION OF TOTAL-BODY POTASSIUM TO HEIGHT, WEIGHT, AND AGE IN NORMAL ADULTS [J].
BODDY, K ;
HUME, R ;
WEYERS, E ;
KING, PC .
JOURNAL OF CLINICAL PATHOLOGY, 1972, 25 (06) :512-&
[3]   Effects of obesity on pharmacokinetics - Implications for drug therapy [J].
Cheymol, G .
CLINICAL PHARMACOKINETICS, 2000, 39 (03) :215-231
[4]   GENTAMICIN THERAPY [J].
DEVINE, BJ .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1974, 8 (11) :650-655
[6]   LEAN BODY-MASS AS A PREDICTOR OF DRUG-DOSAGE - IMPLICATIONS FOR DRUG-THERAPY [J].
MORGAN, DJ ;
BRAY, KM .
CLINICAL PHARMACOKINETICS, 1994, 26 (04) :292-307
[7]   COMPARISON OF FAT-FREE MASS OF YOUNG ADULTS ESTIMATED BY ANTHROPOMETRY, BODY DENSITY AND TOTAL BODY POTASSIUM CONTENT [J].
WOMERSLEY, J ;
BODDY, K ;
KING, PC ;
DURNIN, JVGA .
CLINICAL SCIENCE, 1972, 43 (03) :469-+
[8]  
1959, STAT B, V40, P1